Search Results - "Calabuig, Marisa"

Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation by Ferra Coll, Christelle, Morgades de la Fe, Mireia, Prieto García, Laura, Vaz, Carlos Pinho, Heras Fernando, María Inmaculada, Bailen Almorox, Rebeca, Garcia‐Cadenas, Irene, Calabuig Muñoz, Marisa, Ripa, Teresa Zudaire, Zanabili Al‐Sibai, Joud, Novoa, Sandra, Aguado, Beatriz, Torrent Catarineu, Anna, López‐Godino, Oriana, Martino Bofarull, Rodrigo, Kwon, Mi, Campos Júnior, Antonio, Caballero Barrigón, Dolores, Ribera Santasusana, Josep‐Maria

“…The outcomes of patients with acute lymphoblastic leukaemia (ALL) presenting relapse after allogeneic stem cell transplant (allo‐SCT) are poor, with few data…”
Get full text

Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation by Pagliuca, Simona, Kulasekararaj, Austin G, Eikema, Dirk-Jan, Piepenbroek, Brian, Iftikhar, Raheel, Satti, Tariq Mahmood, Griffin, Morag, Laurino, Marica, Kupesiz, Alphan, Bertrand, Yves, Fattizzo, Bruno, Yakoub-Agha, Ibrahim, Aljurf, Mahmoud, Corti, Paola, Massaccesi, Erika, Lioure, Bruno, Calabuig, Marisa, Klammer, Matthias, Unal, Emel, Wu, Depei, Chevallier, Patrice, Forcade, Edouard, Snowden, John A, Ozdogu, Hakan, Risitano, Antonio, De Latour, Régis Peffault

“…Androgens represent the historical therapeutic backbone of bone marrow failure (BMF) syndromes. However, their role has rarely been analyzed in a prospective…”
Get full text

Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients by Torres, Ignacio, Huntley, Dixie, Tormo, Mar, Calabuig, Marisa, Hernández-Boluda, Juan Carlos, Terol, María José, Carretero, Carlos, de Michelena, Paula, Pérez, Ariadna, Piñana, José Luis, Colomina, Javier, Solano, Carlos, Navarro, David

“…To investigate the multi-drug resistant bacteria (MDRB) colonization rate in hematological patients hospitalized for any cause using a multi-body-site…”
Get full text

Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine by Martín, Iván, Navarro, Blanca, Serrano, Alicia, Villamón, Eva, Calabuig, Marisa, Solano, Carlos, Chaves, Felipe Javier, Yagüe, Nuria, Orts, Maribel, Amat, Paula, Fuentes, Azahara, Seda, Enrique, García, Francisca, Hernández-Boluda, Juan Carlos, Tormo, Mar

“…Azacitidine (AZA) is a DNA hypomethylation agent administered in myeloid neoplasms; however, there is still a lack of established predictors of response. We…”
Get full text

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients by Piñana, José Luis, Vazquez, Lourdes, Calabuig, Marisa, López-Corral, Lucia, Martin-Martin, Gabriel, Villalon, Lucia, Sanz-Linares, Gabriela, Conesa-Garcia, Venancio, Sanchez-Salinas, Andrés, Gago, Beatriz, Facal, Ana, Risco-Gálvez, Irene, Olave, María T., Espigado, Ildefonso, Lopez-Jimenez, Javier, Hernández-Rivas, José Ángel, Avendaño-Pita, Alejandro, Arroyo, Ignacio, Ferrer, Elena, García-Cadenas, Irene, González-Santillana, Clara, Roldán-Pérez, Alicia, Ferrer, Blanca, Guerreiro, Manuel, Suarez-Lledó, María, Camara, Angela, Campos-Beltrán, Diana, Navarro, David, Cedillo, Ángel, Sureda, Anna, Solano, Carlos, Martino, Rodrigo

“…The long-term clinical efficacy of SARS-CoV-2 vaccines according to antibody response in immunosuppressed patients such as hematological patients has been…”
Get full text

Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection and Guidance of Preemptive Therapy for Allogeneic Hematopoietic Stem Cell Transplant Recipients by Gimeno, Concepción, Solano, Carlos, Latorre, José C, Hernández-Boluda, Juan C, Clari, María A, Remigia, María J, Furió, Santiago, Calabuig, Marisa, Tormo, Nuria, Navarro, David

“…The performance of a plasma real-time PCR (cytomegalovirus [CMV] PCR kit; Abbott Diagnostics) was compared with that of the antigenemia assay for the…”
Get full text

Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes by Caballero, Juan Carlos, Dávila, Julio, López-Pavía, María, Such, Esperanza, Bernal, Teresa, Ramos, Fernando, Calabuig, Marisa, Hernández Sánchez, Jesús María, Pomares, Helena, Sánchez Barba, Mercedes, Abáigar, María, González, Bernardo, Merchán, Brayan, Sancho-Tello, Reyes, Callejas, Marta, Muñoz-Novas, Carolina, Cerveró, Carlos, Sanz, Guillermo, Hernández Rivas, Jesús María, Díez Campelo, María

“…Erythropoiesis stimulating agents (ESAs) are the first-line therapy in patients with lower-risk myelodysplastic syndromes (LR-MDS). Some predictive factors for…”
Get full text

Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD by Vilorio-Marqués, Laura, Castañón Fernández, Christelle, Mora, Elvira, Gutiérrez, Lorena, Rey Bua, Beatriz, Jiménez Lorenzo, Maria José, Díaz Beya, Marina, Vara Pampliega, Miriam, Molero, Antonieta, Sánchez-García, Joaquín, Calabuig, Marisa, Cedena, Maria Teresa, Chen-Liang, Tzu, Díaz Santa, Johana Alejandra, Padilla, Irene, Hernández, Francisca, Díez, Rosana, Asensi, Pedro, Xicoy, Blanca, Sanz, Guillermo, Valcárcel, David, Diez-Campelo, María, Bernal, Teresa

“…Background: The consequences of infectious toxicity of hypomethylating agents (HMAs) on overall survival (OS) of patients diagnosed with high-risk myeloid…”
Get full text

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study by Pleyer, Lisa, Leisch, Michael, Kourakli, Alexandra, Padron, Eric, Maciejewski, Jaroslaw Pawel, Xicoy Cirici, Blanca, Kaivers, Jennifer, Ungerstedt, Johanna, Heibl, Sonja, Patiou, Peristera, Hunter, Anthony Michael, Mora, Elvira, Geissler, Klaus, Dimou, Maria, Jimenez Lorenzo, Maria-José, Melchardt, Thomas, Egle, Alexander, Viniou, Athina-Nora, Patel, Bhumika Jayantibhai, Arnan, Montserrat, Valent, Peter, Roubakis, Christoforos, Bernal del Castillo, Teresa, Galanopoulos, Athanasios, Calabuig Muñoz, Marisa, Bonadies, Nicolas, Medina de Almeida, Antonio, Cermak, Jaroslav, Jerez, Andrés, Montoro, Maria Julia, Cortés, Albert, Avendaño Pita, Alejandro, Lopez Andrade, Bernardo, Hellstroem-Lindberg, Eva, Germing, Ulrich, Sekeres, Mikkael Aaron, List, Alan Francis, Symeonidis, Argiris, Sanz, Guillermo Francisco, Larcher-Senn, Julian, Greil, Richard

“…Approval of hypomethylating agents in patients with chronic myelomonocytic leukaemia is based on trials done in patients with myelodysplastic syndromes. We…”
Get full text

Stroke in a Multiple Myeloma Patient Treated With Thalidomide by Ortín, Xavier, Rodríguez-Luaces, Marta, Calabuig, Marisa, Font, Llorenç

“…The antiangiogenic and immunomodulatory properties of thalidomide have led to its use and evaluation in refractory or relapsed multiple myeloma (MM). 1,2…”
Get full text

Complexity of the genetic contribution of different thrombotic risk factors in a Spanish thrombophilic family by Ortiz, Amparo Santamaría

Get more information

Incidence and clinical correlates of NFE2 mutations in myeloid neoplasms by Martín Castillo, Iván, Villamón, Eva, Calabuig, Marisa, Pastor, Irene, Ferrer-Lores, Blanca, Amat, Paula, Mas, Eva, Castillo, Inma, Blanco, Sara, Solano, Carlos, Hernández-Boluda, Juan Carlos, Tormo, Mar

Get full text

Ceftolozane Pharmacokinetics in a Septic Critically Ill Patient under Different Extracorporeal Replacement Therapies by Carbonell, Nieves, Aguilar, Gerardo, Ferriols, Rafael, Huerta, Rotzel, Ferreres, José, Calabuig, Marisa, Juan, Mar, Ezquer, Carlos, Colomina, Javier, Blasco, M Luisa

Get full text

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents by Park, Sophie, Hamel, Jean-François, Toma, Andrea, Kelaidi, Charikleia, Thépot, Sylvain, Campelo, Maria Diez, Santini, Valeria, Sekeres, Mikkael A, Balleari, Enrico, Kaivers, Jennifer, Sapena, Rosa, Götze, Katharina, Müller-Thomas, Catharina, Beyne-Rauzy, Odile, Stamatoullas, Aspasia, Kotsianidis, Ioannis, Komrokji, Rami, Steensma, David P, Fensterl, Jaime, Roboz, Gail J, Bernal, Teresa, Ramos, Fernando, Calabuig, Marisa, Guerci-Bresler, Agnès, Bordessoule, Dominique, Cony-Makhoul, Pascale, Cheze, Stéphane, Wattel, Eric, Rose, Christian, Vey, Norbert, Gioia, Daniela, Ferrero, Dario, Gaidano, Gianluca, Cametti, Giovanni, Pane, Fabrizio, Sanna, Alessandro, Germing, Ulrich, Sanz, Guillermo F, Dreyfus, François, Fenaux, Pierre

“…Purpose Most anemic patients with non-deleted 5q lower-risk myelodysplastic syndromes (MDS) are treated with erythropoiesis-stimulating agents (ESAs), with a…”
Get full text

Current Use of Androgens in Bone Marrow Failure Disorders: A Report from the Severe Aplastic Anemia Working Party (SAAWP) of the European Society of Blood and Marrow Transplantation (EBMT) by Pagliuca, Simona, Kulasekararaj, Austin, Eikema, Dirk-Jan, Piepenbroek, Brian, Iftikhar, Raheel, Satti, Tariq Mahmood, Griffin, Morag, Laurino, Marica, Kupesiz, O. Alphan, Bertrand, Yives, Fattizzo, Bruno, Yakoub-Agha, Ibrahim, Aljurf, Mahmoud, Corti, Paola, Massaccesi, Erika, Lioure, Bruno, Calabuig, Marisa, Klammer, Matthias, Unal, Emel, Wu, Depei, Chevallier, Patrice, Forcade, Edouard, Snowden, John A., Ozdogu, Hakan, Risitano, Antonio, Peffault de Latour, Régis

Get full text

EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome by Hernani, Rafael, Aiko, Mika, Victorio, Ruth, Benzaquén, Ana, Pérez, Ariadna, Piñana, José Luis, Hernández-Boluda, Juan Carlos, Amat, Paula, Pastor-Galán, Irene, Remigia, María José, Ferrer-Lores, Blanca, Micó, Mireia, Carbonell, Nieves, Ferreres, José, Blasco-Cortés, María Luisa, Santonja, José Miguel, Dosdá, Rosa, Estellés, Rocío, Campos, Salvador, Martínez-Ciarpaglini, Carolina, Ferrández-Izquierdo, Antonio, Goterris, Rosa, Gómez, Montse, Teruel, Anabel, Saus, Ana, Ortiz, Alfonso, Morello, Daniela, Martí, Edel, Carretero, Carlos, Calabuig, Marisa, Tormo, Mar, Terol, María José, Cases, Paula, Solano, Carlos

“…•EEG prior to antigen receptor T-cell (CAR-T) infusion is an additional tool to identify patients at risk of neurotoxicity.•Increased severity and higher…”
Get full text

Molecular Classification of Chronic Myelomonocytic Leukemia: Results of the Analysis of an International Cohort of 2,471 Patients by Lanino, Luca, Hunter, Anthony M., Sala, Claudia, Dall'Olio, Daniele, Dall'Olio, Lorenzo, Pleyer, Lisa, Xicoy, Blanca, Meggendorfer, Manja, Sauta, Elisabetta, Travaglino, Erica, Robin, Marie, Palomo, Laura, Quintela, David, Jerez, Andres, Cornejo, Elena, Garcia Martin, Paloma, Díaz-Beyá, Marina, Avendaño Pita, Alejandro, Roldan, Veronica, Fiallo Suarez, Dolly Viviana, Cerezo Velasco, Estefania, Calabuig, Marisa, Rivoli, Giulia, Bernardi, Massimo, Onida, Francesco, Borin, Lorenza Maria, Passamonti, Francesco, Campagna, Alessia, Ubezio, Marta, Russo, Antonio, Todisco, Gabriele, Maggioni, Giulia, Tentori, Cristina Astrid, Viviani, Filippo, Buizza, Alessandro, Asti, Gianluca, Zampini, Matteo, Santoro, Armando, Kern, Wolfgang, Platzbecker, Uwe, Sole, Francesc, Diez-Campelo, Maria, Consagra, Angela, Al Ali, Najla H, Sallman, David A, Fenaux, Pierre, Itzykson, Raphael, Fontenay, Michaela, Zeidan, Amer M., Komrokji, Rami S., Santini, Valeria, Haferlach, Torsten, Germing, Ulrich, D'Amico, Saverio, Castellani, Gastone, Solary, Eric, Padron, Eric, Della Porta, Matteo Giovanni

“…Background. Chronic myelomonocytic leukemia (CMML) is a rare myeloid neoplasm that shares both dysplastic and proliferative features and includes patients with…”
Get full text

Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations by Martín, Iván, Villamón, Eva, Abellán, Rosario, Calasanz, Maria José, Irigoyen, Aroa, Sanz, Guillermo, Such, Esperanza, Mora, Elvira, Gutiérrez, Míriam, Collado, Rosa, García‐Serra, Rocío, Vara, Míriam, Blanco, Mª Laura, Oiartzabal, Itziar, Álvarez, Sara, Bernal, Teresa, Granada, Isabel, Xicoy, Blanca, Jerez, Andrés, Calabuig, Marisa, Diez, Rosana, Gil, Ángela, Díez-Campelo, María, Solano, Carlos, Tormo, Mar

“…Summary In myelodysplastic syndromes (MDS), the 20q deletion [del(20q)] may cause deletion of the ASXL1 gene. We studied 153 patients with MDS and del(20q) to…”
Get full text

Risk-Adapted Intensive Chemotherapy for Primary ACUTE Myeloid Leukemia during the Last 25 YEARS: Increase in Complete Remission RATE, Hematopoietic Cell Transplantation Access and Decrease in Relapse Incidence Have LED to Improved Survival by Garrido, Ana, Hoyos, Montserrat, Diaz-Beyá, Marina, Arnan, Montserrat, Vives, Susana, Calabuig, Marisa, Salamero, Olga, Gallardo, David, Queipo De Llano, Maria Paz, Escoda, Lourdes, Sampol, Antonia, Vall-Llovera, Ferran, Garcia-Guiñon, Antonio, Brayan, Merchan, Bargay, Joan, Torres, J Pio, Ortin, Xavier, Amigo, M Luz, Moraleda, Jose Maria, Falantes, José F., Valcarcel, David, Tormo, Mar, Ribera, Josep-Maria, Brunet, Salut, Sureda Balari, Anna, Esteve, Jordi, Sierra, Jorge

“…The progress in the understanding of pathophysiology of AML has allowed the identification of genetic and immune abnormalities with prognostic impact on…”
Get full text

Myelodysplastic Syndromes with 20q Deletion: Incidence, Prognostic Value and Impact on Response to Azacitidine of ASXL1 Chromosomal Deletion and Genetic Mutations by Martín, Iván, Villamón, Eva, Abellán, Rosario, Calasanz, Maria Jose, Irigoyen, Aroa, Sanz, Guillermo F, Such, Esperanza, Mora Casterá, Elvira, Gutiérrez, Míriam, Collado, Rosa, Vara, Míriam, Blanco, Laura, Oiartzabal, Itziar, Álvarez, Sara, Bernal del Castillo, Teresa, Granada, Isabel, Xicoy, Blanca, Zamora, Lurdes, Jerez, Andres, Fernández, Raquel, Calabuig, Marisa, García, Francisca, Sanz, Alejandro, Díez, Rosana, Gil, Ángela, de Paz, Raquel, López, Francisca, González, Teresa, Solano, Carlos, Tormo, Mar

“…Introduction: The 20q deletion [del(20q)] is a recurrent chromosomal aberration in myelodysplastic syndromes (MDS) and, as a single abnormality, is associated…”
Get full text